SLC30A5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.474600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.275600E-02
Normal-vs-Stage2
6.913200E-01
Normal-vs-Stage3
1.929830E-01
Normal-vs-Stage4
2.180600E-01
Stage1-vs-Stage2
9.540500E-02
Stage1-vs-Stage3
6.503000E-03
Stage1-vs-Stage4
9.523000E-01
Stage2-vs-Stage3
6.330200E-02
Stage2-vs-Stage4
1.537550E-01
Stage3-vs-Stage4
3.667700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.310200E-01
Normal-vs-AfricanAmerican
2.468400E-01
Normal-vs-Asian
6.571200E-01
Caucasian-vs-AfricanAmerican
3.532400E-01
Caucasian-vs-Asian
7.203700E-02
AfricanAmerican-vs-Asian
7.161900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.446600E-01
Normal-vs-Female
6.412400E-01
Male-vs-Female
9.711000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.721640E-01
Normal-vs-Age(41-60Yrs)
4.117200E-01
Normal-vs-Age(61-80Yrs)
7.721000E-01
Normal-vs-Age(81-100Yrs)
9.308600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.038400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.751000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.780800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.427800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.719630E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.024600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.585600E-01
Normal-vs-Daily Drinker
9.781600E-01
Normal-vs-Weekly Drinker
8.705600E-01
Normal-vs-Occasional Drinker
3.152000E-01
Normal-vs-Social Drinker
4.758000E-01
Non Drinker-vs-Daily Drinker
7.778800E-01
Non Drinker-vs-Weekly Drinker
9.585800E-01
Non Drinker-vs-Occasional Drinker
9.558900E-03
Non Drinker-vs-Social Drinker
9.078400E-02
Daily Drinker-vs-Weekly Drinker
8.009200E-01
Daily Drinker-vs-Occasional Drinker
4.341700E-02
Daily Drinker-vs-Social Drinker
1.178800E-01
Weekly Drinker-vs-Occasional Drinker
5.018300E-02
Weekly Drinker-vs-Social Drinker
1.314990E-01
Occasional Drinker-vs-Social Drinker
8.982800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.095770E-01
Normal-vs-Grade 2
1.288080E-02
Normal-vs-Grade 3
3.047600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.989800E-01
Grade 1-vs-Grade 3
8.679600E-01
Grade 1-vs-Grade 4
1.095770E-01
Grade 2-vs-Grade 3
7.326000E-01
Grade 2-vs-Grade 4
1.288080E-02
Grade 3-vs-Grade 4
3.047600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.897600E-01
Normal-vs-NonDiabetic
7.389800E-01
Diabetic-vs-NonDiabetic
4.987400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.033400E-01
Normal-vs-NoPancreatitis
7.109600E-01
Pancreatitis-vs-NoPancreatitis
6.377200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.610600E-01
Normal-vs-N1
6.994400E-01
N0-vs-N1
2.762800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.397800E-01
Normal-vs-TP53-NonMutant
4.026800E-01
TP53-Mutant-vs-TP53-NonMutant
4.695800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
